No registrations found.
ID
Source
Health condition
Small vessel disease, SVDs, VCI, lacunar infarcts
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary Objective:
To assess which measures of microvascular function on 7T MRI are affected in patients with symptomatic SVDs, relative to controls
Secondary outcome
Secondary Objective(s):
To establish how microvascular function relates to:
• parenchymal lesion presence at baseline and lesion progression after 24 months
• cognitive function at baseline and cognitive decline after 24 months
• blood pressure (BP) and BP variability
Background summary
Zoom@SVDs is a longitudinal observational study with 7T MRI in 60 patients with sporadic SVDs and 30 healthy controls and in 15 patients with CADASIL. Primary objective is to determine which novel 7T markers of microvascular malfunction most clearly differentiate patients with SVDs from healthy controls. Secondary objectives are to explore the relation between microvascular function and parenchymal lesion presence at baseline and lesion progression after 24 months and to relate microvascular function to BP and BP variability (BPv) and to cognitive dysfunction.
Study objective
Current approaches to study and diagnose SVD focus on lesion-detection with MRI. However, SVD-lesions represent an end-stage and are insufficiently specific to understand disease processes. It would be a major advance if SVDs in humans could also be examined in terms of microvascular function. High field strength imaging with 7TMRI now offers this possibility. In Zoom@SVDs we will use 7T MRI to assess which aspects of microvascular function are affected in patients with symptomatic SVDs and how microvascular function relates to other markers of SVD-related brain injury and cognition.
Study design
Baseline will be divided over two days.
Follow-up will be preformed after 24 months.
Intervention
Observational study.
Participants will undergo: an interview with full medical history and examination. Cognitive testing, a 3T MRI scan and a 7T MRI scan. Participants will be issued with a BP machine with telemonitoring capabilities and instructed to perform home BP monitoring with the device over seven days.
GJ Biessels
Utrecht
The Netherlands
0887556866
g.j.biessels@umcutrecht.nl
GJ Biessels
Utrecht
The Netherlands
0887556866
g.j.biessels@umcutrecht.nl
Inclusion criteria
• Symptomatic sporadic SVD defined as
o History of clinical lacunar stroke in the last 5 years with a corresponding recent small subcortical infarct visible on MRI scan or CT scan* compatible with the clinical syndrome.
*On MRI, recent infarct is defined as a DWI lesion on the acute MRI scan. On CT, recent infarct is defined as a novel infarct on CT within 3 weeks after the event that was not visible on the admission CT.
o or cognitive impairment defined as visiting a memory clinic with cognitive complaints, and a CDR score of ≥0.5, and capacity to consent, and with confluent WMH on MRI (defined as a Fazekas WMH score ≥ 2)16
• Age 18 years or older
• Written informed consent
Exclusion criteria
• Inclusion criteria are not met
• Evidence for a monogenic for of SVDs
• Unwillingness or inability to give written consent
• Pregnant or breastfeeding women, women of childbearing age not taking contraception.
• Contraindications to MRI (pacemaker, aneurysm clip, cochlear implant etc.)
• Other major neurological or psychiatric conditions affecting the brain and interfering with the study design (e.g. multiple sclerosis, epilepsy, Parkinson’s disease)
• In case of inclusion for clinical lacunar stroke other causes of stroke such as
o ≥50% luminal stenosis (NASCET) in large arteries supplying the infarct area
o major-risk cardioembolic source of embolism (permanent or paroxysmal atrial fibrillation, sustained atrial flutter, intracardiac thrombus, prosthetic cardiac valve, atrial myxoma or other cardiac tumours, mitral stenosis, recent (<4 weeks) myocardial infarction, left ventricular ejection fraction less than 30%, valvular vegetations, or infective endocarditis)
o other specific causes of stroke (e.g. arteritis, dissection, migraine/ vasospasm, drug misuse)
• Life expectancy <2 years
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL6126 |
| NTR-old | NTR6265 |
| CCMO | NL58737.041.16 |
| OMON | NL-OMON47570 |